BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q1 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 3/28/2024- NAV $57.53
- NAV Change $-0.42
- Market Price $57.54
- Market Price Change $-0.55
- Trading Volume (M) 34,738
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 3/28/2024- NAV $57.53
- NAV Change $-0.42
- Market Price $57.54
- Market Price Change $-0.55
- Trading Volume (M) 34,738
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 12/29/2023
Holdings
as of 3/27/2024
Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
---|---|---|---|---|---|---|
52.12% | -- | NASDAQ BIO INDEX SWAP BNP | 50,595,708 | -- | 11,380 | -- |
24.90% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 24,168,565 | -- | 5,436 | -- |
23.64% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 22,950,355 | -- | 5,162 | -- |
15.27% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 14,823,031 | -- | 3,334 | -- |
6.05% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,873,192 | -- | 1,321 | -- |
5.91% | -- | AMGEN INC COMMON STOCK USD 0.0001 | -- | $5,739,742.40 | 20,048 | -- |
5.73% | GILD | GILEAD SCIENCES INC | -- | $5,558,981.40 | 76,140 | 2369174 |
5.66% | REGN | REGENERON PHARMACEUTICALS | -- | $5,491,482.90 | 5,683 | 2730190 |
5.61% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $5,445,191.36 | 13,048 | 2931034 |
4.77% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,632,753 | -- | 1,042 | -- |
3.13% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 3,036,632 | -- | 683 | -- |
3.05% | MRNA | MODERNA INC | -- | $2,961,268.43 | 26,777 | BGSXTS3 |
2.87% | -- | ASTRAZENECA PLC ADR USD | -- | $2,785,554.08 | 40,808 | -- |
2.27% | BIIB | BIOGEN INC | -- | $2,203,855.58 | 10,187 | 2455965 |
1.59% | ILMN | ILLUMINA INC | -- | $1,544,201.80 | 11,135 | 2613990 |
1.40% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,362,800.53 | 8,827 | B00FWN1 |
1.21% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $1,171,512.81 | 13,221 | 2437071 |
1.01% | VTRS | VIATRIS INC | -- | $984,539.92 | 83,224 | BMWS3X9 |
0.99% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $961,364.25 | 6,975 | 2623911 |
0.98% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $953,237.25 | 31,305 | BMVP7Y0 |
0.98% | SNY | SANOFI-ADR | -- | $951,019.38 | 19,197 | 2964557 |
0.93% | INCY | INCYTE CORP | -- | $898,840.32 | 15,736 | 2471950 |
0.90% | MEDP | MEDPACE HOLDINGS INC | -- | $869,450.12 | 2,156 | BDCBC61 |
0.90% | ARGX | ARGENX SE - ADR | -- | $869,324.79 | 2,181 | BDVLM39 |
0.88% | SRPT | SAREPTA THERAPEUTICS INC | -- | $856,652.94 | 6,578 | B8DPDT7 |
0.83% | UTHR | UNITED THERAPEUTICS CORP | -- | $802,547.73 | 3,299 | 2430412 |
0.65% | BNTX | BIONTECH SE-ADR | -- | $630,801.45 | 6,785 | BK6H543 |
0.63% | ROIV | ROIVANT SCIENCES LTD | -- | $612,178.16 | 56,474 | BMW4NZ9 |
0.62% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $597,471.00 | 4,025 | BV9G6B8 |
0.54% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $526,387.68 | 4,368 | B4Q5ZN4 |
0.54% | PCVX | VAXCYTE INC | -- | $520,326.00 | 7,596 | BKPVGH6 |
0.53% | CYTK | CYTOKINETICS INC | -- | $515,365.97 | 7,217 | BBBSBJ5 |
0.52% | EXEL | EXELIXIS INC | -- | $507,001.14 | 21,249 | 2576941 |
0.51% | APLS | APELLIS PHARMACEUTICALS INC | -- | $494,357.48 | 8,452 | BYTQ6X1 |
0.49% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $473,119.92 | 6,786 | BHCB0P4 |
0.47% | IONS | IONIS PHARMACEUTICALS INC | -- | $456,246.56 | 10,216 | BDJ0LS6 |
0.46% | BGNE | BEIGENE LTD-ADR | -- | $450,042.16 | 2,902 | BYYWPW6 |
0.42% | BPMC | BLUEPRINT MEDICINES CORP | -- | $406,838.68 | 4,292 | BWY52P3 |
0.41% | CRSP | CRISPR THERAPEUTICS AG | -- | $394,720.16 | 5,626 | BDHF4K6 |
0.39% | BBIO | BRIDGEBIO PHARMA INC | -- | $380,256.92 | 12,322 | BK1KWG8 |
0.38% | RVMD | REVOLUTION MEDICINES INC | -- | $366,143.96 | 11,543 | BL71K91 |
0.37% | HALO | HALOZYME THERAPEUTICS INC | -- | $361,967.51 | 8,887 | 2975098 |
0.37% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $361,039.95 | 1,395 | BD59BS7 |
0.36% | KRYS | KRYSTAL BIOTECH INC | -- | $351,210.40 | 1,982 | BD6JX35 |
0.34% | IMVT | IMMUNOVANT INC | -- | $331,118.64 | 10,182 | BJRFSB7 |
0.33% | ALKS | ALKERMES PLC | -- | $319,043.00 | 11,708 | B3P6D26 |
0.33% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $317,954.05 | 5,585 | BMX9K07 |
0.32% | NUVL | NUVALENT INC-A | -- | $314,990.40 | 4,110 | BMVBZD3 |
0.29% | INSM | INSMED INC | -- | $284,264.60 | 10,405 | 2614487 |
0.28% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $275,993.40 | 19,574 | BF0DMK7 |
0.28% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $270,198.22 | 5,771 | BJ62Z18 |
0.27% | AXSM | AXSOME THERAPEUTICS INC | -- | $262,765.23 | 3,319 | BYZR4X4 |
0.27% | ACLX | ARCELLX INC | -- | $260,594.55 | 3,699 | BPCJ1Q2 |
0.27% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $259,017.00 | 5,170 | BGMGM89 |
0.26% | IBRX | IMMUNITYBIO INC | -- | $255,484.32 | 46,792 | BNSP0B8 |
0.26% | FTRE | FORTREA HOLDINGS INC | -- | $249,377.76 | 6,222 | BRXYZ57 |
0.26% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $249,230.80 | 8,684 | BYQBFJ8 |
0.25% | FOLD | AMICUS THERAPEUTICS INC | -- | $245,502.00 | 20,700 | B19FQ48 |
0.23% | XENE | XENON PHARMACEUTICALS INC | -- | $227,298.00 | 5,286 | BRJ3GY4 |
0.23% | IDYA | IDEAYA BIOSCIENCES INC | -- | $226,251.44 | 5,224 | BK0VHF6 |
0.22% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $216,773.97 | 4,879 | BDD19F8 |
0.22% | -- | ACADIA PHARMACEUTICALS INC COMMON STOCK USD 0.0001 | -- | $210,191.80 | 11,549 | -- |
0.21% | DNLI | DENALI THERAPEUTICS INC | -- | $202,549.04 | 9,752 | BD2B4V0 |
0.20% | ARVN | ARVINAS INC | -- | $197,226.76 | 4,772 | BDZ30Q0 |
0.20% | BEAM | BEAM THERAPEUTICS INC | -- | $194,353.08 | 5,723 | BK6L288 |
0.19% | SMMT | SUMMIT THERAPEUTICS INC | -- | $184,406.25 | 49,175 | BMTVQS7 |
0.19% | NTLA | INTELLIA THERAPEUTICS INC | -- | $182,006.72 | 6,736 | BYZM6C2 |
0.19% | MRUS | MERUS NV | -- | $181,550.75 | 4,057 | BZBY005 |
0.18% | ALPN | ALPINE IMMUNE SCIENCES INC | -- | $177,558.10 | 4,594 | BYX38M1 |
0.18% | APGE | APOGEE THERAPEUTICS INC | -- | $177,426.55 | 2,605 | BM9HHL5 |
0.18% | VCEL | VERICEL CORP | -- | $177,084.72 | 3,384 | BSBMN89 |
0.18% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $176,061.27 | 4,213 | BF2YWG4 |
0.18% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $172,846.75 | 6,343 | BDFKQ07 |
0.18% | KYMR | KYMERA THERAPEUTICS INC | -- | $172,048.11 | 4,283 | BMPRZV5 |
0.17% | KROS | KEROS THERAPEUTICS INC | -- | $163,072.52 | 2,522 | BM7V485 |
0.17% | DYN | DYNE THERAPEUTICS INC | -- | $162,022.50 | 5,685 | BN15WD1 |
0.17% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $161,896.23 | 15,919 | BM9FJ13 |
0.17% | VERA | VERA THERAPEUTICS INC | -- | $161,294.40 | 3,680 | BL55460 |
0.16% | PTCT | PTC THERAPEUTICS INC | -- | $158,033.92 | 5,368 | B17VCN9 |
0.16% | SANA | SANA BIOTECHNOLOGY INC | -- | $154,500.00 | 15,450 | BMFJJ97 |
0.16% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $153,609.28 | 2,416 | BLCD809 |
0.16% | GH | GUARDANT HEALTH INC | -- | $153,198.80 | 8,530 | BFXC911 |
0.15% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $146,662.40 | 3,370 | BNFWZS4 |
0.15% | -- | STRUCTURE THERAPEUTICS INC ADR USD 0.0001 | -- | $146,408.92 | 3,412 | -- |
0.14% | TWST | TWIST BIOSCIENCE CORP | -- | $139,712.96 | 4,052 | BGKG6G7 |
0.14% | RNA | AVIDITY BIOSCIENCES INC | -- | $137,855.96 | 5,588 | BMWHPY1 |
0.14% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $137,381.85 | 5,955 | BN7Q7R7 |
0.14% | MYGN | MYRIAD GENETICS INC | -- | $134,798.60 | 6,299 | 2614153 |
0.14% | JANX | JANUX THERAPEUTICS INC | -- | $134,540.16 | 3,548 | BMFX8Y7 |
0.14% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $133,309.04 | 3,977 | BKSGZN7 |
0.13% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $129,359.16 | 3,834 | B72ZBG4 |
0.13% | GERN | GERON CORP | -- | $126,663.77 | 38,267 | 2370381 |
0.13% | -- | 4D MOLECULAR THERAPEUTICS INC COMMON STOCK USD 0.0001 | -- | $125,150.43 | 3,489 | -- |
0.12% | -- | ARDELYX INC COMMON STOCK USD 0.000001 | -- | $120,842.28 | 16,308 | -- |
0.12% | MORF | MORPHIC HOLDING INC | -- | $120,571.34 | 3,506 | BK8M4J4 |
0.12% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $117,189.00 | 6,525 | BKY5JZ8 |
0.12% | INBX | INHIBRX INC | -- | $116,733.15 | 3,321 | BK1MBC3 |
0.12% | -- | PROTAGONIST THERAPEUTICS INC COMMON STOCK USD 0.00001 | -- | $116,283.84 | 4,083 | -- |
0.12% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $114,645.44 | 3,937 | BCBVTX1 |
0.12% | VCYT | VERACYTE INC | -- | $114,290.64 | 5,262 | BFTWZY0 |
0.12% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $113,601.14 | 9,154 | BRJZSK0 |
0.12% | KURA | KURA ONCOLOGY INC | -- | $112,963.12 | 5,336 | BYZD465 |
0.11% | NVCR | NOVOCURE LTD | -- | $109,858.56 | 7,504 | BYSS4X4 |
0.11% | FUSN | FUSION PHARMACEUTICALS INC | -- | $108,054.90 | 5,073 | BJK0NH0 |
0.11% | -- | ADMA BIOLOGICS INC COMMON STOCK USD 0.0001 | -- | $107,792.82 | 15,993 | -- |
0.11% | AVDL | AVADEL PHARMACEUTICALS-ADR | -- | $105,906.76 | 6,289 | BDTZ028 |
0.11% | ANIP | ANI PHARMACEUTICALS INC | -- | $102,862.44 | 1,476 | BCDWBX6 |
0.11% | IRON | DISC MEDICINE INC | -- | $102,261.90 | 1,690 | BMGJZJ8 |
0.10% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $96,682.17 | 6,123 | BLB0YH0 |
0.10% | AKRO | AKERO THERAPEUTICS INC | -- | $96,455.25 | 3,945 | BK7Y2V9 |
0.10% | XNCR | XENCOR INC | -- | $96,024.86 | 4,283 | BGCYWN8 |
0.10% | VIR | VIR BIOTECHNOLOGY INC | -- | $95,566.20 | 9,462 | BK4PZ38 |
0.10% | PRTA | PROTHENA CORP PLC | -- | $94,727.40 | 3,765 | B91XRN2 |
0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $94,670.40 | 3,260 | B3X26D8 |
0.10% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $94,570.02 | 10,971 | B3MZ6K5 |
0.09% | ABCL | ABCELLERA BIOLOGICS INC | -- | $92,125.82 | 20,518 | BL53SR3 |
0.09% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $91,638.40 | 2,240 | BX7RSN3 |
0.09% | GMAB | GENMAB A/S -SP ADR | -- | $89,990.94 | 2,938 | BBC9WC7 |
0.09% | LGND | LIGAND PHARMACEUTICALS | -- | $88,446.07 | 1,241 | 2501578 |
0.09% | MNKD | MANNKIND CORP | -- | $87,743.13 | 18,951 | BF081J4 |
0.09% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $85,949.16 | 5,662 | BZ1LFB2 |
0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $82,933.43 | 2,399 | BMH5RL1 |
0.08% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $82,041.92 | 3,266 | BJDX8Y8 |
0.08% | SAGE | SAGE THERAPEUTICS INC | -- | $80,234.56 | 4,214 | BP4GNK9 |
0.08% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $79,545.18 | 9,271 | BMCWKZ2 |
0.08% | VRNA | VERONA PHARMA PLC - ADR | -- | $78,573.00 | 4,762 | BYWPZK5 |
0.08% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $78,115.20 | 5,056 | BFZQ0L8 |
0.08% | VERV | VERVE THERAPEUTICS INC | -- | $77,293.40 | 5,860 | BNKGXX2 |
0.08% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $75,555.06 | 4,974 | BMQ5T49 |
0.08% | RLAY | RELAY THERAPEUTICS INC | -- | $75,014.88 | 9,193 | BN2R582 |
0.08% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $74,407.20 | 14,448 | 2100362 |
0.08% | ETNB | 89BIO INC | -- | $73,876.92 | 6,532 | BK1K484 |
0.07% | OCUL | OCULAR THERAPEUTIX INC | -- | $71,919.75 | 7,725 | BNZB1X8 |
0.07% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $71,211.82 | 3,422 | BMGS7L1 |
0.07% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $69,857.88 | 18,779 | B4N8MH9 |
0.07% | RGNX | REGENXBIO INC | -- | $69,090.70 | 3,115 | BZ0G875 |
0.07% | INVA | INNOVIVA INC | -- | $67,749.99 | 4,431 | BDDXF67 |
0.07% | SPRY | ARS PHARMACEUTICALS INC | -- | $67,010.88 | 6,728 | BMCR7V2 |
0.07% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $65,077.74 | 6,786 | BKX9VD3 |
0.07% | MGNX | MACROGENICS INC | -- | $65,046.08 | 4,348 | BFDV8K0 |
0.07% | ORIC | ORIC PHARMACEUTICALS INC | -- | $63,568.27 | 4,721 | BKVDFF7 |
0.06% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $61,579.64 | 1,874 | BKC9SX3 |
0.06% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $61,551.36 | 9,864 | BFMLGR4 |
0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $61,415.55 | 4,221 | BMDWW66 |
0.06% | -- | BICYCLE THERAPEUTICS PLC ADR USD 0.01 | -- | $61,375.00 | 2,500 | -- |
0.06% | GRFS | GRIFOLS SA-ADR | -- | $56,844.20 | 8,548 | B8K7T65 |
0.06% | ZLAB | ZAI LAB LTD-ADR | -- | $56,195.49 | 3,471 | BD9GVY0 |
0.06% | EOLS | EVOLUS INC | -- | $56,070.00 | 4,005 | BDRJH21 |
0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $55,991.99 | 2,801 | BD0MGM0 |
0.06% | PRME | PRIME MEDICINE INC | -- | $55,215.68 | 8,168 | BPBJFM7 |
0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $55,039.60 | 7,148 | BP2P6L0 |
0.06% | -- | ENLIVEN THERAPEUTICS INC COMMON STOCK USD 0.01 | -- | $53,784.81 | 2,887 | -- |
0.05% | CGEM | CULLINAN ONCOLOGY INC | -- | $53,154.54 | 2,998 | BM90J52 |
0.05% | -- | ALLOGENE THERAPEUTICS INC COMMON STOCK USD 0.001 | -- | $52,592.32 | 11,792 | -- |
0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $51,654.08 | 8,552 | BYZG9R0 |
0.05% | CABA | CABALETTA BIO INC | -- | $51,501.45 | 3,003 | BK5MWR1 |
0.05% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $50,670.00 | 10,134 | BFWLC09 |
0.05% | YMAB | Y-MABS THERAPEUTICS INC | -- | $50,638.50 | 3,069 | BG31GH0 |
0.05% | ZYME | ZYMEWORKS INC | -- | $50,531.80 | 4,906 | BPCQZY9 |
0.05% | NRIX | NURIX THERAPEUTICS INC | -- | $49,814.04 | 3,426 | BMVLGP2 |
0.05% | CVAC | CUREVAC NV | -- | $47,857.55 | 15,691 | BN4RD42 |
0.05% | NVAX | NOVAVAX INC | -- | $47,568.80 | 9,808 | BJDQXG4 |
0.05% | COGT | COGENT BIOSCIENCES INC | -- | $47,478.64 | 7,282 | BLR6XK8 |
0.05% | SLRN | ACELYRIN INC | -- | $46,048.50 | 6,822 | BQPF874 |
0.05% | SVRA | SAVARA INC | -- | $46,002.25 | 9,485 | BYXGN81 |
0.05% | GLPG | GALAPAGOS NV-SPON ADR | -- | $45,569.85 | 1,383 | B292NQ7 |
0.05% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $44,343.65 | 4,013 | BJLKVS6 |
0.05% | OABI | OMNIAB INC | -- | $43,906.94 | 8,146 | BN13S71 |
0.05% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $43,856.10 | 3,951 | BLB0YQ9 |
0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $43,243.20 | 3,861 | BMZ4LN0 |
0.04% | EDIT | EDITAS MEDICINE INC | -- | $42,668.40 | 5,735 | BZ8FPH3 |
0.04% | SIGA | SIGA TECHNOLOGIES INC | -- | $42,338.50 | 4,981 | 2107437 |
0.04% | TSHA | TAYSHA GENE THERAPIES INC | -- | $41,536.51 | 13,103 | BNC1BX1 |
0.04% | TRML | TOURMALINE BIO INC | -- | $41,128.40 | 1,796 | BQ80NC6 |
0.04% | FULC | FULCRUM THERAPEUTICS INC | -- | $41,065.86 | 4,341 | BJDX8Z9 |
0.04% | CSTL | CASTLE BIOSCIENCES INC | -- | $40,964.00 | 1,925 | BKLCWZ3 |
0.04% | TVTX | TRAVERE THERAPEUTICS INC | -- | $40,904.11 | 5,333 | BLFGJD5 |
0.04% | -- | ALECTOR INC COMMON STOCK USD 0.0001 | -- | $40,796.80 | 6,710 | -- |
0.04% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $39,843.72 | 3,492 | BLN7XQ1 |
0.04% | -- | ANAPTYSBIO INC COMMON STOCK USD 0.001 | -- | $39,830.94 | 1,863 | -- |
0.04% | BMEA | BIOMEA FUSION INC | -- | $38,415.36 | 2,501 | BNKF6N0 |
0.04% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $37,453.38 | 17,102 | BWFZX59 |
0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $36,831.96 | 2,882 | BP9N0G0 |
0.04% | HCM | HUTCHMED CHINA-ADR | -- | $36,615.05 | 2,173 | BYXV9H7 |
0.04% | VYGR | VOYAGER THERAPEUTICS INC | -- | $36,375.80 | 3,805 | BY7RB53 |
0.04% | LYEL | LYELL IMMUNOPHARMA INC | -- | $36,326.28 | 17,807 | BN6MB18 |
0.04% | PETQ | PETIQ INC | -- | $35,682.24 | 2,046 | BDH65C8 |
0.04% | REPL | REPLIMUNE GROUP INC | -- | $35,499.75 | 4,303 | BDDVW37 |
0.03% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $33,851.25 | 3,825 | BM8MVZ3 |
0.03% | ITOS | ITEOS THERAPEUTICS INC | -- | $33,017.19 | 2,507 | BMWXFT4 |
0.03% | URGN | UROGEN PHARMA LTD | -- | $32,373.44 | 2,164 | BZ7PJQ1 |
0.03% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $32,257.98 | 2,914 | BD06CS0 |
0.03% | CRBU | CARIBOU BIOSCIENCES INC | -- | $31,733.76 | 6,198 | BNYJR68 |
0.03% | TBPH | THERAVANCE BIOPHARMA INC | -- | $31,453.91 | 3,491 | BMNDK09 |
0.03% | MXCT | MAXCYTE INC | -- | $31,363.20 | 7,260 | BKMQF66 |
0.03% | HROW | HARROW INC | -- | $31,315.80 | 2,460 | BHNDW86 |
0.03% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $30,555.20 | 11,752 | BZ0QMB7 |
0.03% | RVNC | REVANCE THERAPEUTICS INC | -- | $30,539.08 | 6,182 | BJFSR99 |
0.03% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $29,382.63 | 10,167 | BJ5FZ74 |
0.03% | -- | ANAVEX LIFE SCIENCES CORP COMMON STOCK USD 0.001 | -- | $29,115.24 | 5,754 | -- |
0.03% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $27,671.76 | 4,456 | BFYQFJ2 |
0.03% | THRD | THIRD HARMONIC BIO INC | -- | $26,800.10 | 2,830 | BNNPQY8 |
0.03% | TERN | TERNS PHARMACEUTICALS INC | -- | $26,672.80 | 4,330 | BMDJ0C9 |
0.03% | PGEN | PRECIGEN INC | -- | $25,295.25 | 17,445 | BKM5C84 |
0.03% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $24,284.59 | 8,767 | BNG1NK8 |
0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $24,108.17 | 4,153 | BMG99Y1 |
0.02% | -- | AMARIN CORP PLC ADR USD 10 | -- | $24,043.97 | 27,040 | -- |
0.02% | AVIR | ATEA PHARMACEUTICALS INC | -- | $23,592.00 | 5,898 | BLN9Z50 |
0.02% | HUMA | HUMACYTE INC | -- | $22,506.00 | 7,260 | BMYTJP4 |
0.02% | ERAS | ERASCA INC | -- | $21,813.34 | 10,589 | BNLYBF3 |
0.02% | -- | RAPT THERAPEUTICS INC COMMON STOCK USD | -- | $21,512.37 | 2,409 | -- |
0.02% | ACIU | AC IMMUNE SA | -- | $20,982.75 | 6,925 | BZC0D70 |
0.02% | ATAI | ATAI LIFE SCIENCES NV | -- | $20,826.65 | 11,635 | BN6M8F1 |
0.02% | -- | XERIS BIOPHARMA HOLDINGS INC COMMON STOCK USD 0.0001 | -- | $19,749.24 | 9,681 | -- |
0.02% | EXAI | EXSCIENTIA PLC | -- | $19,542.18 | 3,381 | BP48134 |
0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $18,885.68 | 7,804 | BRK0149 |
0.02% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $18,610.50 | 1,425 | BL95N25 |
0.02% | BLUE | BLUEBIRD BIO INC | -- | $18,210.47 | 13,341 | BBFL7S1 |
0.02% | QURE | UNIQURE NV | -- | $18,145.14 | 3,354 | BJFSR88 |
0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $15,680.59 | 4,031 | B12W3P6 |
0.02% | OVID | OVID THERAPEUTICS INC | -- | $15,106.65 | 4,953 | BYPFK63 |
0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $13,677.12 | 4,749 | BPCK358 |
0.01% | -- | ACHILLION PHARMACEUTICALS INC - CVR | -- | $11,641.22 | 25,307 | -- |
0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $11,283.41 | 22,107 | BM9CKX3 |
0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $6,264.72 | 4,972 | BYV2W40 |
-- | -- | RENEO PHARMACEUTICALS INC COMMON STOCK USD 0.0001 | -- | $3,852.75 | 2,335 | -- |
-- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
-- | -- | TREASURY BILL | -- | $14,715,740.25 | 15,000,000 | BRYQ9Y9 |
-- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $14,363,313.35 | 14,363,313 | -- |
Index
as of 12/29/2023
- Total Number of Companies225
- Price/Earnings Ratio--
- Price/Book Ratio4.289
- Dividend Yield ( % )0.79
- Avg. Index Market Capitalization$6.63 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
- 2024
- 2023
- 2022
Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
---|